MONDAY, Feb. 24, 2025 -- People taking the weight-loss drug semaglutide could be at a slightly increased risk for a potentially blinding eye...

Weight-loss drugs could soon be used to treat depression following a landmark study.

By Birgitta Dresp-Langley Digital technology and Artificial Intelligence (AI) pose threats to human right to freedom of thought [1], identified in...

MONDAY, Feb. 24, 2025 -- For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with...

The hormone glucagon-like peptide 1 (GLP-1) is effective in controlling insulin release and reducing appetite. It is marketed as Semaglutide, Ozempic...

FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2...

THURSDAY, Feb. 20, 2025 -- The societal stress and stigma of being LGBTQ+ can increase a person’s risk of mental health problems, a new study...

THURSDAY, Feb. 20, 2025 -- Both perceived and actual overweight status may be associated with suicidal ideation among adolescents, according to a...

FRIDAY, Feb. 28, 2025 -- For young people with type 1 diabetes, hybrid closed-loop insulin delivery does not affect the rate of severe hypoglycemia...

WEDNESDAY, Feb. 26, 2025 -- A person dies by suicide once every 43 seconds, and it’s more than likely a man, according to a new global...